GeNeuro SA (GNRO.PA)
EUR 0.08
(-1.57%)
EUR 0.08
(-1.57%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.59 EUR | -15.69% |
| 2022 | -0.51 EUR | -59.38% |
| 2021 | -0.32 EUR | 28.89% |
| 2020 | -0.45 EUR | 30.77% |
| 2019 | -0.65 EUR | -14.04% |
| 2018 | -0.57 EUR | -42.5% |
| 2017 | -0.40 EUR | 60.78% |
| 2016 | -1.02 EUR | -175.68% |
| 2015 | -0.37 EUR | -346.67% |
| 2014 | 0.15 EUR | 151.72% |
| 2013 | -0.29 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q4 | -0.32 EUR | 0.0% |
| 2023 FY | - EUR | -15.69% |
| 2023 Q2 | -0.28 EUR | 0.0% |
| 2022 Q4 | -0.26 EUR | 0.0% |
| 2022 FY | - EUR | -59.38% |
| 2022 Q2 | -0.25 EUR | 0.0% |
| 2021 Q4 | -0.15 EUR | 0.0% |
| 2021 Q2 | -0.17 EUR | 0.0% |
| 2021 FY | - EUR | 28.89% |
| 2020 FY | - EUR | 30.77% |
| 2020 Q4 | -0.25 EUR | 0.0% |
| 2020 Q2 | -0.20 EUR | 0.0% |
| 2019 FY | - EUR | -14.04% |
| 2019 Q4 | -0.34 EUR | 0.0% |
| 2019 Q2 | -0.31 EUR | 0.0% |
| 2018 Q4 | -0.41 EUR | 0.0% |
| 2018 Q2 | -0.16 EUR | 0.0% |
| 2018 FY | - EUR | -42.5% |
| 2017 Q4 | 0.15 EUR | 0.0% |
| 2017 Q2 | -0.55 EUR | 0.0% |
| 2017 FY | - EUR | 60.78% |
| 2016 Q4 | -0.56 EUR | 0.0% |
| 2016 FY | - EUR | -175.68% |
| 2016 Q2 | -0.45 EUR | 0.0% |
| 2015 Q2 | -0.14 EUR | 0.0% |
| 2015 FY | - EUR | -346.67% |
| 2015 Q4 | -0.23 EUR | 0.0% |
| 2014 Q3 | 0.04 EUR | 122.88% |
| 2014 Q1 | 0.04 EUR | 0.0% |
| 2014 Q2 | -0.16 EUR | -537.16% |
| 2014 FY | - EUR | 151.72% |
| 2014 Q4 | 0.30 EUR | 719.67% |
| 2013 FY | - EUR | 0.0% |
| 2013 Q1 | -0.07 EUR | 0.0% |
| 2013 Q3 | -0.07 EUR | 0.0% |
| 2013 Q4 | 0.04 EUR | 150.69% |
| 2013 Q2 | -0.07 EUR | 0.0% |
| 2012 Q4 | -0.07 EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| ABIONYX Pharma SA | -0.12 EUR | -391.667% |
| ABIVAX Société Anonyme | -3.43 EUR | 82.799% |
| Adocia SA | -1.91 EUR | 69.11% |
| Aelis Farma SA | -0.39 EUR | -51.282% |
| Biophytis S.A. | -12.55 EUR | 95.299% |
| Advicenne S.A. | -0.67 EUR | 11.94% |
| genOway Société anonyme | 0.17 EUR | 447.059% |
| IntegraGen SA | -0.03 EUR | -2177.992% |
| Medesis Pharma S.A. | -0.80 EUR | 26.25% |
| Neovacs S.A. | -0.00 EUR | -23500.0% |
| NFL Biosciences SA | -0.46 EUR | -28.261% |
| Plant Advanced Technologies SA | 0.07 EUR | 942.857% |
| Quantum Genomics Société Anonyme | -0.09 EUR | -548.352% |
| Sensorion SA | -0.17 EUR | -247.059% |
| Theranexus Société Anonyme | -0.88 EUR | 32.955% |
| TME Pharma N.V. | -1.34 EUR | 55.97% |
| Valbiotis SA | -0.59 EUR | -0.0% |
| TheraVet SA | -0.49 EUR | -20.408% |
| Valerio Therapeutics Société anonyme | -0.15 EUR | -293.333% |
| DBV Technologies S.A. | -0.71 EUR | 16.901% |
| Genfit S.A. | -0.58 EUR | -1.724% |
| Innate Pharma S.A. | -0.09 EUR | -526.993% |
| Inventiva S.A. | -2.43 EUR | 75.72% |
| MaaT Pharma SA | -1.73 EUR | 65.896% |
| MedinCell S.A. | -0.88 EUR | 32.955% |
| Nanobiotix S.A. | -1.08 EUR | 45.37% |
| OSE Immunotherapeutics SA | -1.18 EUR | 50.0% |
| Poxel S.A. | -0.91 EUR | 35.165% |
| GenSight Biologics S.A. | -0.54 EUR | -9.259% |
| Transgene SA | -0.22 EUR | -168.182% |
| Valneva SE | -0.73 EUR | 19.178% |